MyFinsight
Home
Blog
About
Cash and cash
equivalents
$4,198K
(103.19%↑ Y/Y)
Prepaid expenses and
other current assets
$173K
(3.59%↑ Y/Y)
Total current assets
$4,371K
(95.75%↑ Y/Y)
Intangible asset
$2,039K
(0.00%↑ Y/Y)
Operating lease
right-of-use assets
$46K
(-43.90%↓ Y/Y)
Other assets
$3K
(0.00%↑ Y/Y)
Total assets
$6,459K
(48.24%↑ Y/Y)
Total liabilities and
stockholders' equity
$6,459K
(48.24%↑ Y/Y)
Total stockholders'
equity (deficit)
$4,997K
(455.41%↑ Y/Y)
Total liabilities
$1,462K
(-74.63%↓ Y/Y)
Accumulated deficit
-$68,400K
(-22.74%↓ Y/Y)
Accumulated other
comprehensive loss
-$242K
(17.97%↑ Y/Y)
Additional paid-in capital
$73,635K
(34.82%↑ Y/Y)
Total current
liabilities
$1,455K
(-74.53%↓ Y/Y)
Operating lease
liabilities
$7K
(-86.27%↓ Y/Y)
Common stock, par value
0.001, 166,666,667...
$4K
(300.00%↑ Y/Y)
Accounts payable and
accrued liabilities
$1,302K
(-73.10%↓ Y/Y)
Due to related
parties
$111K
(326.92%↑ Y/Y)
Operating lease
liabilities - current...
$42K
(16.67%↑ Y/Y)
Back
Back
Balance Sheet
ARTELO BIOSCIENCES, INC. (ARTL)
ARTELO BIOSCIENCES, INC. (ARTL)
source: myfinsight.com